Top 10 Stocks — Ranked by Conviction
1
NVDA — NVIDIA Corporation
AI GPU monopoly, data center revenue tripling, $80B+ buyback, dominant moat
▲
2
MSFT — Microsoft Corporation
Azure AI acceleration, Copilot monetization, cloud sticky recurring revenue
▲
3
META — Meta Platforms
Ad targeting AI improvements driving revenue, AI infrastructure costs declining
▲
4
LLY — Eli Lilly & Company
GLP-1 weight loss drug secular tailwind, tirzepatide manufacturing scaling
▲
5
BRK.B — Berkshire Hathaway
Defensive value, $300B+ cash ready to deploy, Buffett succession priced in
▲
6
AMZN — Amazon
AWS re-acceleration, advertising growth, retail margin improvement thesis
▲
7
GOOGL — Alphabet
Search AI moat holding, YouTube growth, Waymo optionality, reasonable valuation
▲
8
JPM — JPMorgan Chase
Best-in-class bank, rate cut cycle manageable, fee income diversification
▲
9
COST — Costco Wholesale
Membership model is recurring revenue, pricing power, resilient consumer demand
▲
10
PLTR — Palantir Technologies
Enterprise AI platform gaining traction, US government contract momentum
▲
Valuation Summary
| Ticker | Price | P/E (FY25) | EPS Growth | Mkt Cap | 12-Mo Target |
|---|---|---|---|---|---|
| NVDA | $875 | 35x | +45% | $2.1T | $1,100 |
| MSFT | $415 | 33x | +14% | $3.1T | $480 |
| META | $590 | 26x | +18% | $1.5T | $720 |
| LLY | $840 | 45x | +25% | $800B | $1,050 |
| BRK.B | $460 | 21x | +8% | $1.0T | $520 |
| AMZN | $210 | 40x | +22% | $2.2T | $260 |
| GOOGL | $180 | 22x | +15% | $2.2T | $220 |
| JPM | $230 | 13x | +9% | $660B | $265 |
| COST | $920 | 52x | +12% | $408B | $1,050 |
| PLTR | $85 | 80x | +28% | $185B | $110 |
Related Reports
Deeper Research
Disclaimer: This report is for informational and educational purposes only. Nothing on this page constitutes financial advice, investment recommendations, or solicitation to buy or sell any security. Past performance does not guarantee future results. Always consult a qualified financial advisor before making investment decisions. Data sourced from public filings and market data providers.